Literature DB >> 20395689

The value of using top-down and bottom-up approaches for building trust and transparency in biobanking.

Eric M Meslin1.   

Abstract

With the domestic and international proliferation of biobanks and their associated connections to health information databases, scholarly attention has been turning from the ethical issues arising from the construction of biobanks to the ethical issues that emerge in their operation and management. Calls for greater transparency in governance structures, coupled with stern reminders of the value of maintaining public trust, are seen as critical components in the success of these resources. Two different approaches have been adopted for addressing these types of ethical issues: the first is a 'top-down' approach which focuses on developing policy, procedures, regulations and guidelines to aid decision-makers. The second is a 'bottom-up' approach, which begins with those who are most affected by the issues and attempts to inductively develop consensus recommendations and policy. While both approaches have merit, I argue that more work needs to be done on 'bottom-up' strategies if trust and transparency are to be more than mere slogans. Using 2 case examples from Indiana, the paper summarizes data from a set of surveys we recently conducted that address issues arising from biobanks that provide some insight into issues associated with trust and transparency. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20395689      PMCID: PMC2865393          DOI: 10.1159/000279622

Source DB:  PubMed          Journal:  Public Health Genomics        ISSN: 1662-4246            Impact factor:   2.000


  24 in total

1.  The charitable trust as a model for genomic biobanks.

Authors:  David E Winickoff; Richard N Winickoff
Journal:  N Engl J Med       Date:  2003-09-18       Impact factor: 91.245

2.  Untapped potential: IRB guidance for the ethical research use of stored biological materials.

Authors:  Leslie E Wolf; Bernard Lo
Journal:  IRB       Date:  2004 Jul-Aug

3.  Creating incentives for genomic research to improve targeting of therapies.

Authors:  Barbara J Evans; David A Flockhart; Eric M Meslin
Journal:  Nat Med       Date:  2004-12       Impact factor: 53.440

4.  Faculty ownership of medical facilities: inappropriate conflict or an opportunity that benefits physicians and patients?

Authors:  Rose S Fife; Patricia Keener; Eric M Meslin; Marcus Randall; Rebecca L Schiffmiller
Journal:  Acad Med       Date:  2004-11       Impact factor: 6.893

5.  The unfinished business of U.S. drug safety regulation.

Authors:  Barbara J Evans; David A Flockhart
Journal:  Food Drug Law J       Date:  2006       Impact factor: 0.619

6.  State codification of federal regulatory ambiguities in biobanking and genetic research.

Authors:  Katherine Drabiak-Syed
Journal:  J Leg Med       Date:  2009 Jul-Sep

7.  Building on relationships of trust in biobank research.

Authors:  M G Hansson
Journal:  J Med Ethics       Date:  2005-07       Impact factor: 2.903

Review 8.  Why might people donate tissue for cancer research? Insights from organ/tissue/blood donation and clinical research.

Authors:  Renata E Axler; Rob Irvine; Wendy Lipworth; Bronwen Morrell; Ian H Kerridge
Journal:  Pathobiology       Date:  2008-12-15       Impact factor: 4.342

9.  US and Scottish health professionals' attitudes toward DNA biobanking.

Authors:  David A Leiman; Nancy M Lorenzi; Jeremy C Wyatt; Alex S F Doney; S Trent Rosenbloom
Journal:  J Am Med Inform Assoc       Date:  2008-02-28       Impact factor: 4.497

10.  Parents' and children's attitudes toward the enrollment of minors in genetic susceptibility research: implications for informed consent.

Authors:  Barbara A Bernhardt; Ellen S Tambor; Gertrude Fraser; Lawrence S Wissow; Gail Geller
Journal:  Am J Med Genet A       Date:  2003-02-01       Impact factor: 2.802

View more
  15 in total

Review 1.  Bioethical considerations in developing a biorepository for the Pneumonia Etiology Research for Child Health project.

Authors:  Andrea N DeLuca; Alan Regenberg; Jeremy Sugarman; David R Murdoch; Orin Levine
Journal:  Clin Infect Dis       Date:  2012-04       Impact factor: 9.079

2.  Research ethics in the era of personalized medicine: updating science's contract with society.

Authors:  Eric M Meslin; Mildred K Cho
Journal:  Public Health Genomics       Date:  2010-08-31       Impact factor: 2.000

3.  Native Hawaiian views on biobanking.

Authors:  Maile Tauali i; Elise Leimomi Davis; Kathryn L Braun; JoAnn Umilani Tsark; Ngiare Brown; Maui Hudson; Wylie Burke
Journal:  J Cancer Educ       Date:  2014-09       Impact factor: 2.037

4.  Reflexive governance in biobanking: on the value of policy led approaches and the need to recognise the limits of law.

Authors:  Graeme Laurie
Journal:  Hum Genet       Date:  2011-07-16       Impact factor: 4.132

5.  'Cool! and creepy': engaging with college student stakeholders in Michigan's biobank.

Authors:  Tevah Platt; Jodyn Platt; Daniel B Thiel; Nicole Fisher; Sharon L R Kardia
Journal:  J Community Genet       Date:  2014-06-12

6.  Altruism in terminal cancer patients and rapid tissue donation program: does the theory apply?

Authors:  Gwendolyn P Quinn; Devin Murphy; Christie Pratt; Teresita Muñoz-Antonia; Lucy Guerra; Matthew B Schabath; Marino E Leon; Eric Haura
Journal:  Med Health Care Philos       Date:  2013-11

7.  Thematic analysis of cardiac care patients' explanations for declining contribution to a genomic research-based biobank.

Authors:  Pamela Holtzclaw Williams; Lynne S Nemeth; Jennifer E Sanner; Lorraine Q Frazier
Journal:  Am J Crit Care       Date:  2013-07       Impact factor: 2.228

8.  Neglected ethical issues in biobank management: Results from a U.S. study.

Authors:  R Jean Cadigan; Dragana Lassiter; Kaaren Haldeman; Ian Conlon; Erik Reavely; Gail E Henderson
Journal:  Life Sci Soc Policy       Date:  2013-12-01

9.  Building trust in 21st century genomics.

Authors:  Michael J Szego; Janet A Buchanan; Stephen W Scherer
Journal:  G3 (Bethesda)       Date:  2013-08-07       Impact factor: 3.154

10.  Building a data sharing model for global genomic research.

Authors:  Patricia Kosseim; Edward S Dove; Carman Baggaley; Eric M Meslin; Fred H Cate; Jane Kaye; Jennifer R Harris; Bartha M Knoppers
Journal:  Genome Biol       Date:  2014-08-11       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.